CSPC Pharmaceutical Group Limited (FRA:CVG)

Market Cap	12.63B
Revenue (ttm)	3.45B
Net Income (ttm)	534.62M
Shares Out	n/a
EPS (ttm)	0.05
PE Ratio	23.62
Forward PE	19.76
Dividend	0.03 (2.79%)
Ex-Dividend Date	Jun 4, 2025

Volume	7,450
Average Volume	4,260
Open	1.072
Previous Close	1.101
Day's Range	1.072 - 1.144
52-Week Range	0.511 - 1.144
Beta	n/a
RSI	70.81
Earnings Date	Aug 20, 2025

About Thoughtworks Holding

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson’s disease; Duomeisu for lymphoma,...

• Industry: Pharmaceutical Preparations
• Founded: 1992
• Employees: 21,400
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CVG

Financial Performance

In 2024, CSPC Pharmaceutical Group's revenue was 29.01 billion, a decrease of -7.76% compared to the previous year's 31.45 billion. Earnings were 4.33 billion, a decrease of -26.31%.